These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8937848)

  • 1. Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices.
    Parker RJ; Collins JM; Strong JM
    Drug Metab Dispos; 1996 Nov; 24(11):1167-73. PubMed ID: 8937848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo metabolism of lidocaine in the rat. Isolation of urinary metabolites as pentafluorobenzoyl derivatives and their identification by combined gas chromatography-mass spectrometry.
    Coutts RT; Torok-Both GA; Chu LV; Tam YK; Pasutto FM
    J Chromatogr; 1987 Oct; 421(2):267-80. PubMed ID: 3429583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct detection of glucuronide metabolites of lidocaine in sheep urine.
    Doran GS; Smith AK; Rothwell JT; Edwards SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1076():84-90. PubMed ID: 29406032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the differences in lidocaine binding and regioselectivity of oxidation by cytochromes P450 2B1 and 2B2.
    Hanna IH; Roberts ES; Hollenberg PF
    Biochemistry; 1998 Jan; 37(1):311-8. PubMed ID: 9425052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of lidocaine in subcellular post-mitochondrial fractions and precision cut slices from cattle liver.
    Punt A; Lautz L; Stoopen G; Pinckaers N; Rijkers D; Essers M; Hoogenboom R
    Toxicol In Vitro; 2021 Oct; 76():105228. PubMed ID: 34311064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.
    Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass metabolism of lidocaine in the anesthetized rabbit. Contribution of the small intestine.
    Lê KT; Maurice H; du Souich P
    Drug Metab Dispos; 1996 Jul; 24(7):711-6. PubMed ID: 8818566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous in vivo metabolism of topical lidocaine formulation in human skin.
    Rolsted K; Benfeldt E; Kissmeyer AM; Rist GM; Hansen SH
    Skin Pharmacol Physiol; 2009; 22(3):124-7. PubMed ID: 19136832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lidocaine and its metabolite as a hepatic function marker in dogs.
    Pérez-Guillé BE; Villegas-Alvarez F; Toledo-López A; Jiménez-Bravo MA; González-Zamora JF; Carrasco-Portugal MC; Flores-Murrieta FJ; Soriano-Rosales RE
    Proc West Pharmacol Soc; 2011; 54():62-5. PubMed ID: 22423583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lidocaine metabolism associated with epidural anesthesia in patients for hepatic surgery].
    Sato T; Ono T; Ozaki M; Sakio H; Yasuda S
    Masui; 1999 Dec; 48(12):1318-22. PubMed ID: 10658411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phenobarbital on the pharmacokinetics of lidocaine, monoethylglycinexylidide and 3-hydroxylidocaine in the rat: correlation with P450 isoform levels.
    Nakamoto T; Oda Y; Imaoka S; Funae Y; Fujimori M
    Drug Metab Dispos; 1997 Mar; 25(3):296-300. PubMed ID: 9172946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems.
    Hartman NR; Mao JJ; Zhou H; Boyne MT; Wasserman AM; Taylor K; Racoosin JA; Patel V; Colatsky T
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):182-8. PubMed ID: 25010377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX).
    Sallie RW; Tredger JM; Williams R
    Biopharm Drug Dispos; 1992 Oct; 13(7):555-8. PubMed ID: 1489946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of dimethylaniline and other metabolites in milk and tissues of dairy cows treated with lidocaine.
    Hoogenboom RL; Zuidema T; Essers M; van Vuuren AM; van Wikselaar PG; van Eijkeren JC; Mengelers MJ; Zeilmaker MJ; Bulder AS
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(8):1256-64. PubMed ID: 26118443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.